[1]彭继英a,杨红杰b,石晓欣a,等.细针穿刺细胞学检查在甲状腺癌碘-131 治疗后复发诊断中的应用价值[J].现代检验医学杂志,2020,35(01):127-129.[doi:10.3969/j.issn.1671-7414.2020.01.033]
　PENG Ji-yinga,YANG Hong-jieb,SHI Xiao-xina,et al.Application Value of Fine Needle Aspiration Cytology in Recurrence Diagnosis of Thyroid Cancer after Iodine-131 Treatment[J].Journal of Modern Laboratory Medicine,2020,35(01):127-129.[doi:10.3969/j.issn.1671-7414.2020.01.033]
点击复制

细针穿刺细胞学检查在甲状腺癌碘-131 治疗后复发诊断中的应用价值 ()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年01期
页码:
127-129
栏目:
检验与临床
出版日期:
2020-02-29

文章信息/Info

Title:
Application Value of Fine Needle Aspiration Cytology in Recurrence Diagnosis of Thyroid Cancer after Iodine-131 Treatment
文章编号:
1671-7414(2020)01-127-03
作者:
彭继英a;  杨红杰b; 石晓欣a;  刘 军a; 尹为华a
(北京大学深圳医院 a.病理科; b.核医学科 518035)
Author(s):
PENG Ji-yinga;  YANG Hong-jieb;  SHI Xiao-xina;  LIU Juna; YIN Wei-huab
(a.Department of Pathology; b.Department of Nuclear Medicine,Shenzhen Hospital of Peking University,Guangdong Shenzhen 518035,China)
关键词:
甲状腺癌;  细针穿刺;  碘-131;  诊断;  应用价值
分类号:
R736.1; R730.43
DOI:
10.3969/j.issn.1671-7414.2020.01.033
文献标志码:
A
摘要:
目的 评价甲状腺癌术后碘-131治疗的疗效,并探究超声引导下细针穿刺细胞学检查在碘-131治疗后复发病例诊断中的应用价值。方法 选择2011年1月～2018年5月期间甲状腺癌术后在北京大学深圳医院接受放射性碘治疗的474例患者进行随访,采用影像学检查筛选甲状腺癌患者的复发情况,并对这部分患者进行细针穿刺细胞学检测以评价细针穿刺细胞学在甲状腺癌复发患者中的诊断学价值。结果 474例甲状腺癌患者在接受碘-131治疗后,定期超声影像学筛查,筛查出甲状腺癌复发患者56例,超声影像学诊断筛查出甲状腺癌患者复发率为11.81%,对可疑复发的患者行细针穿刺细胞学检查及组织病理学检查,细针穿刺细胞学检查筛查出甲状腺癌复发患者50例,组织病理学检查证实甲状腺癌复发患者50例,经病理学修正后碘-131治疗后甲状腺癌患者复发率为10.55%,超声影像学检查对甲状腺癌患者复发诊断的符合率89.29%,细针穿刺细胞学诊断复发符合率为100%。结论 超声影像学检查是甲状腺癌患者常规使用的复查手段,而对于超声检查发现的可疑淋巴结进行超声引导下细针穿刺细胞学检查的准确率优于单纯的超声影像学检查。
Abstract:
Objective To evaluate the efficacy of postoperativeiodine-131 therapy in thyroid cancer, and explore the value of ultrasound-guided fine needle aspiration cytology in the diagnosis of recurrent cases after iodine-131 treatment. Methods Patients who underwent radioactive iodine treatment in Peking University Shenzhen Hospital from January 2011 to May 2018 were selected for follow-up.The recurrence rate of thyroid cancer patients after iodine-131 treatment was calculated, and 56 patients with thyroid cancer recurrence were screened.The diagnostic value of fine needle aspiration cytology in patients with recurrent thyroid cancer was evaluated. Results A total of 474 patients with thyroid cancer who underwent iodine-131 treatment underwent regular ultrasound imaging screening, and 56 patients with thyroid cancer recurrence were screened. The recurrence rate of thyroid cancer patients diagnosed by ultrasound imaging was 11.81%. Fine needle aspiration cytology and histopathological examination were performed in patientswith suspected recurrence, 50 cases of thyroid cancer recurrence were detected by fine needle aspiration cytology, 50 cases of thyroid cancer recurrence confirmed by histopathological examination, pathological correction and the recurrence rate of thyroid cancer patients after treatment with post-iodine-131 was 10.97%. The coincidence rate of ultrasound imaging examination for recurrence diagnosis of thyroid cancer patients was 89.28%, and the coincidence rate of fine needle aspiration cytology diagnosis was 100%. Conclusion Ultrasound imaging is a routine review method for thyroid cancer patients, and the accuracy of ultrasound-guided fine needle aspiration cytology for suspicious lymph nodes detected by ultrasonography is better than that of pure ultrasound imaging.

参考文献/References:

[1] SIPOS J A, MAZZAFERRI E L. Thyroid cancer epidemiology and prognostic variables[J]. Clinical Oncology, 2010, 22(6): 395-404.
[2] 蔡慧,吕超,丁一波,等.2004-2011年上海市原卢湾区居民甲状腺癌的发病率及死亡率分析[J].中国临床医学,2017,24(5):728-731. CAI Hui, LÜ Chao, DING Yibo,et al. Incidence and mortality of thyroid cancer among permanent residents in Luwan district of Shanghai during 2004-2011[J]. Chinese Journal of Clinical Medicine,2017,24(5):728-731
[3] CHEN Wanqing, ZHENG Rongshou, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer Journal for Clinicians, 2016, 66(2): 115-132.
[4] 邵佳娴,欧阳萱艺,周利杰,等.甲状腺结节应用甲状腺细针穿刺辅助检查临床价值分析[J].浙江创伤外科,2017,22(3):444-445. SHAO Jiaxian, OUYANG Xuanyi, ZHOU Lijie, et al. Clinical value of thyroid nodules assisted by thyroid fine needle puncture [J]. Zhejiang Journal of Traumatic Surgery,2017,22(3):444-445.
[5] 张永文,张晓立,梅海云,等.甲状腺结节诊疗规范探讨[J].湖南中医药大学学报,2017,37(6):659-663. ZHANG Yongwen, ZHANG Xiaoli, MEI Haiyun, et al. Discussion on diagnosis and treatment standards of thyroid nodules [J]. Journal of Traditional Chinese Medicine University of Hunan,2017,37(6):659-663.
[6] 殷德涛,刘晨光.甲状腺癌的放射治疗[J].中国实用外科杂志,2019,39(3):206-208. YIN Detao, LIU Chenguang. Radiotherapy for thyroid cancer [J]. Chinese Journal of Practical Surgery, 2019, 39(3):206-208.
[7] 谢晖.超声诊断甲状腺癌颈部淋巴结转移的临床分析[J].中国医药指南,2018,16(18):108-109. XIE Hui. Clinical analysis of ultrasound diagnosis of cervical lymph node metastasis in thyroid carcinoma[J].Guide of China Medicine,2018,16(18):108-109.
[8] 李晨,李建宁,杨裕辉,等.超声引导下细针穿刺细胞学检查在甲状腺微小结节良恶性鉴别诊断中的应用价值[J].中国临床医学影像杂志,2017,28(3):223-225. LI Chen, LI Jianning, YANG Yuhui, et al.The value of ultrasound-guided fine needle aspiration cytology in differential diagnosis of benign and malignant thyroid nodules [J]. Journal of China Clinic Medical Imaging, 2017, 28(3):223-225.
[9] 俞惠新,张莉,谭成,等.碘-131辐射引起甲状腺乳头状癌BCPAP细胞发生多核化[C].//中华医学会内分泌分会. 中华医学会第十二次全国内分泌学学术会议论文集,西安,2013:280-281. YU Huixin,ZHANG Li,TAN Cheng,et al. Polynucleation of BCPAP cells in papillary thyroid carcinoma induced by iodine 131 radiation [C]. // Chinese Society Endocrinology of Chinese Medical Association.Proceedings of the 12th national endocrinology academic conference of Chinese Medical Association,Xi'an,2013:280-281.
[10] 李小民,黄作良.细针穿刺细胞学检查在甲状腺癌诊断中的应用研究[J].中国医药指南,2015,13(8):1, 3. LI Xiaomin, HUANG Zuoliang. To application research of fine needle aspiration cytology in thyroid cancer early diagnosis [J].Guide of China Medicine,2015,13(8):1,3.
[11] 劳艳明,马洪,张广俊,等.超声引导下细针穿刺细胞学检查鉴别甲状腺结节良恶性的临床价值[J].中国中西医结合影像学杂志,2019,17(1):59-61. LAO Yanming, MA Hong, ZHANG Guangjun, et al. Clinical value of ultrasound-guided fine needle aspiration cytology in diagnosis of benign and malignant thyroid nodules [J]. Chinese Imaging Journal of Integrated Traditional and Western Medicine,2019,17(1):59-61.

相似文献/References:

[1]赵芳芳,郭　红,陈　嘉.LncRNA TUG1 在甲状腺癌组织中的表达及其对细胞增殖和迁移的影响[J].现代检验医学杂志,2020,35(06):42.[doi:doi:10.3969/j.issn.1671-7414.2020.06.011]
　ZHAO Fang-fang,GUO Hong,CHEN Jia.Expression of LncRNA TUG1 in Thyroid Carcinoma Tissues and Its Effect onCell Proliferation and Migration[J].Journal of Modern Laboratory Medicine,2020,35(01):42.[doi:doi:10.3969/j.issn.1671-7414.2020.06.011]
[2]仲亚东,孔德桐,马伯敏.甲状腺癌患者组织及手术前后血清中NR3C2 和ZEB1 表达水平及其与预后价值研究[J].现代检验医学杂志,2023,38(04):94.[doi:10.3969/j.issn.1671-7414.2023.04.017]
　ZHONG Yadong,KONG Detong,MA Bomin.Study on the Expression Level of NR3C2 and ZEB1 in Thyroid Cancer Tissue and Serum of Patients before and after Surgery and Their Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(01):94.[doi:10.3969/j.issn.1671-7414.2023.04.017]
[3]谈玖婷,傅聿明,刘 婧,等.甲状腺癌组织中DCBLD2 和MAP4K3 的表达及与临床病理特征及预后的关系[J].现代检验医学杂志,2024,39(02):34.[doi:10.3969/j.issn.1671-7414.2024.02.007]
　TAN Jiuting,FU Yuming,LIU Jing,et al.Expression of DCBLD2 and MAP4K3 in Thyroid Cancer Tissue and Their Relationship with Clinico-pathological Features and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(01):34.[doi:10.3969/j.issn.1671-7414.2024.02.007]
[4]张廷华a,胡友元b,袁 博.miR-100-5p 对甲状腺癌细胞增殖与凋亡调控作用的实验研究[J].现代检验医学杂志,2024,39(04):56.[doi:10.3969/j.issn.1671-7414.2024.04.011]
　ZHANG Tinghuaa,HU Youyuanb,YUAN Bo.Experimental Study on the Regulatory Effects of miR-100-5p on Proliferation and Apoptosis of Thyroid Cancer Cells[J].Journal of Modern Laboratory Medicine,2024,39(01):56.[doi:10.3969/j.issn.1671-7414.2024.04.011]
[5]汪明阳,曹忠超,王艳超,等.甲状腺癌组织中KDM1A和UCHL3的表达与临床病理学特征及预后的关系研究[J].现代检验医学杂志,2025,40(01):105.[doi:10.3969/j.issn.1671-7414.2025.01.020]
　WANG Mingyang,CAO Zhongchao,WANG Yanchao,et al.Study on the Expression of KDM1A and UCHL3 in Thyroid Cancer Tissue and Relationship with the Clinical Pathological Features and Prognosis[J].Journal of Modern Laboratory Medicine,2025,40(01):105.[doi:10.3969/j.issn.1671-7414.2025.01.020]

备注/Memo

备注/Memo:
基金项目:深圳市三名工程项目(SZSM20182088)。 作者简介:彭继英(1979-),女,病理学硕士,主治医师,研究方向: 病理科医师,E-mail:pengjiying@126.com。 通讯作者:尹为华。收稿日期:2019-02-29 修回日期:2019-05-29
更新日期/Last Update: 2020-03-30